Literature DB >> 23866878

Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.

Robert A Schwartz1, Patrick H McDonough, Brian W Lee.   

Abstract

Toxic epidermal necrolysis is a life-threatening, typically drug-induced mucocutaneous disease. It is clinically characterized as a widespread sloughing of the skin and mucosa, including both external and internal surfaces. Histologically, the denuded areas show full thickness epidermal necrosis. The pathogenic mechanism involves antigenic moiety/metabolite, peptide-induced T cell activation, leading to keratinocyte apoptosis through soluble Fas ligand, perforin/granzyme B, tumor necrosis factor-alfa, and nitric oxide. Recent studies have implicated granulysin in toxic epidermal necrolysis apoptosis and have suggested that it may be the pivotal mediator of keratinocyte death.
Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  ALDEN; APC; BSA; CD40 ligand; CD40L; EM; Fas ligand; FasL; HLA; MHC; NF-κB; NK; NO; PBMC; SJS; Stevens–Johnson syndrome; TEN; algorithm for drug causality for epidermal necrolysis; antigen presenting cell; apoptosis; body surface area; drug eruption; erythema multiforme; granulysin; human leukocyte antigen; major histocompatibility complex; natural killer; nitric oxide; nuclear factor kappaB; peripheral blood mononuclear cell; sFasL; serum Fas ligand; toxic epidermal necrolysis

Mesh:

Year:  2013        PMID: 23866878     DOI: 10.1016/j.jaad.2013.05.003

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  61 in total

1.  Toxic epidermal necrolysis with the use of tamoxifen.

Authors:  Irappa Madabhavi; Swaroop Revannasiddaiah; Apurva Patel; Asha Anand
Journal:  BMJ Case Rep       Date:  2015-04-15

2.  Localised bullous eruptions and epidermal detachment from the extravasation of hydroxyethyl starch (Voluven).

Authors:  James London; Stan Tay; Brigid Brown; Chasari Tancharoen
Journal:  BMJ Case Rep       Date:  2014-12-22

3.  RIPping the Skin Apart: Necroptosis Signaling in Toxic Epidermal Necrolysis.

Authors:  Diana Panayotova-Dimitrova; Maria Feoktistova; Martin Leverkus
Journal:  J Invest Dermatol       Date:  2015-08       Impact factor: 8.551

4.  Stevens-Johnson syndrome with a recall-like reaction within a donor graft site.

Authors:  Maleka Najmi; Leigha Sharp; Michelle Tarbox; Cloyce Stetson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-17

5.  Toxic epidermal necrolysis associated with radiotherapy and phenytoin in a patient with non-Hodking's lymphoma: A case report.

Authors:  Fatma Keklik; Melda Cömert Özkan; Gizem Kocabaş Yenipazar; Banu Yaman; Güray Saydam; Fahri Şahin
Journal:  Rep Pract Oncol Radiother       Date:  2015-10-17

Review 6.  [Mucosal diseases from an allergological perspective].

Authors:  I Schwarz; D Bokanovic; W Aberer
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

7.  Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis.

Authors:  Sue Kyung Kim; Woo-Jung Kim; Jung-Ho Yoon; Jae-Hoon Ji; Michael J Morgan; Hyeseong Cho; You Chan Kim; You-Sun Kim
Journal:  J Invest Dermatol       Date:  2015-03-06       Impact factor: 8.551

8.  Metolazone Associated Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap.

Authors:  Prabhat Kumar; Ajay Chauhan; Riyaz Charaniya; Anindya Ghosh; Vaibhav Tandon
Journal:  J Clin Diagn Res       Date:  2016-03-01

9.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Authors:  Naga Chalasani; Herbert L Bonkovsky; Robert Fontana; William Lee; Andrew Stolz; Jayant Talwalkar; K Rajendar Reddy; Paul B Watkins; Victor Navarro; Huiman Barnhart; Jiezhun Gu; Jose Serrano
Journal:  Gastroenterology       Date:  2015-03-06       Impact factor: 22.682

10.  Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.

Authors:  Leelawadee Techasatian; Sunee Panombualert; Rattapon Uppala; Charoon Jetsrisuparb
Journal:  World J Pediatr       Date:  2016-09-20       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.